254P Real-world clinical scenarios during introduction of trastuzumab biosimilar for HER2-positive breast cancer von Wyrwicz, L., Rodríguez Sanchez, C.A., Sanchez-Rovira, P., Lewis, S., Sandschafer, D., San, T.

Volltext

MT17 Assessment of Device Failures and Medication Errors with the Pegfilgrastim on-Body Injector in the US and EU von Sandschafer, D, Choi, A, Lewis, S, Upchurch, T, De Oliveira Brandao, C

Volltext

P-202 Demographics and clinical characteristics of metastatic colorectal cancer patients treated with a biosimilar to bevacizumab von Rhodes, W., Accortt, N., DeClue, R., Jin, R., Sandschafer, D., Wertz, D., Patel, K.

Volltext